Public annual accounts

Dr. Pans-Lindekens Elke financials

Name: Dr. Pans-Lindekens Elke financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Pans-Lindekens Elke, with comparable measures and links to available source documents.

Company overview

Registry number

0835424970

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Dr. Pans-Lindekens Elke

2025 versus 2024

Operating line: €115,323
EBITDA: €114,770
Total assets: €284,286
Equity: €251,271

EBITDA margin +99.5% · Equity ratio +88.4%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€115,323	€114,770	€284,286	€251,271	-
202430 Jun 2024	€52,753	€51,185	€270,166	€242,924	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Jun 2025

€115,323

€114,770

€284,286

€251,271

202430 Jun 2024

€52,753

€51,185

€270,166

€242,924